Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials

Most academic precision oncology programs have been designed to facilitate enrollment of patients in early clinical trials with matched targeted agents. Over the last decade, major changes were seen both in the targetable molecular alteration landscape and in drug development trends. In this article...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: Dienstmann, Rodrigo, Garralda, Elena, Aguilar, Susana, Sala, Gemma, Viaplana, Cristina, Ruiz-Pace, Fiorella, González-Zorelle, Jenifer, Grazia LoGiacco, Deborah, Ogbah, Zighereda, Ramos Masdeu, Laia, Mancuso, Francesco, Fasani, Roberta, Jimenez, Jose, Martinez, Paola, Oaknin, Ana, Saura, Cristina, Oliveira, Mafalda, Balmaña, Judith, Carles, Joan, Macarulla, Teresa, Elez, Elena, Alsina, Maria, Braña, Irene, Felip, Enriqueta, Tabernero, Josep, Rodon, Jordi, Nuciforo, Paolo, Vivancos, Ana
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2020
Matèries:
Special Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446427/
https://ncbi.nlm.nih.gov/pubmed/32923891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00398
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars